Clinical Trials · NCT07533175
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 630
- Start date
- Apr 2026
- Locations
- 74 sites, 10 countries
- Primary endpoint
- Relative change in body weight